• Publications
  • Influence
Neonatal abstinence syndrome after methadone or buprenorphine exposure.
BACKGROUND Methadone, a full mu-opioid agonist, is the recommended treatment for opioid dependence during pregnancy. However, prenatal exposure to methadone is associated with a neonatal abstinenceExpand
  • 507
  • 28
  • PDF
Neonatal abstinence syndrome after methadone or buprenorphine exposure
ABSTRACTThe recommended treatment for opioid dependence in pregnant women is methadone, a full mu-opioid agonist. However, in utero exposure to methadone is associated with neonatal abstinenceExpand
  • 213
  • 24
Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers.
The subjective and physiological effects of intravenously administered cocaine and nicotine were compared in 10 cigarette-smoking cocaine abusers. Subjects abstained from smoking at least 8 h beforeExpand
  • 93
  • 12
  • PDF
Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.
This study was designed to compare the neonatal abstinence syndrome (NAS) in neonates of methadone and buprenorphine maintained pregnant opioid-dependent women and to provide preliminary safety andExpand
  • 263
  • 10
  • PDF
Treatment of opioid-dependent pregnant women: clinical and research issues.
This article addresses common questions that clinicians face when treating pregnant women with opioid dependence. Guidance, based on both research evidence and the collective clinical experience ofExpand
  • 153
  • 8
Suicidality, aggression, and other treatment considerations among pregnant, substance-dependent women with posttraumatic stress disorder.
Posttraumatic stress disorder (PTSD) and other Axis I comorbidity among women with substance use disorders (SUDs) appear similarly prevalent and are associated with comparable negative clinicalExpand
  • 33
  • 8
Clinical care for opioid-using pregnant and postpartum women: the role of obstetric providers.
We review clinical care issues that are related to illicit and therapeutic opioid use among pregnant women and women in the postpartum period and outline the major responsibilities of obstetricsExpand
  • 69
  • 7
  • PDF
Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance
Objectives: The prevalence of opioid use disorder (OUD) during pregnancy is increasing. Practical recommendations will help providers treat pregnant women with OUD and reduce potentially negativeExpand
  • 68
  • 7
  • PDF
Unintended pregnancy in opioid-abusing women.
The aim of this study was to estimate the prevalence of unintended pregnancy and its three subtypes (mistimed, unwanted, and ambivalent) among opioid-abusing women. In the general population, 31%-47%Expand
  • 146
  • 6
  • PDF
Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.
AIMS To compare the profile of signs of neonatal abstinence syndrome (NAS) in methadone- versus buprenorphine-exposed infants. DESIGN, SETTING AND PARTICIPANTS Secondary analysis of NAS data from aExpand
  • 73
  • 6
  • PDF